2017 Clinical Trials Sleep 
MGC Pharma
FEBRUARY 20, 2018
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Peninsula Alternative Health
MAY 15, 2019
Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CannaMD
JUNE 2, 2021
. * The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. More than 80% of survey respondents indicated strong interest in learning more information about a clinical trial, and more than half were interested in enrolling in a clinical trial.
Canna Care Docs
DECEMBER 11, 2018
It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. Sleep: Disruptions in sleep are very common in older adults, especially those who are taking certain prescribed medications.
Project CBD
FEBRUARY 28, 2023
CBD first appeared on the natural channel’s top 40 list in 2017, ranking 12th, after sales growth of more than 300% from the previous year. million more on CBD products in 2021 compared to 2017 — a 413.4% Approved cannabinoids for medical purposes: Comparative systematic review and meta-analysis for sleep and appetite.
Cannabis Law Report
FEBRUARY 2, 2022
The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern.
Healer
MARCH 26, 2021
A 2017 review of existing studies by researchers Suzanna Nielsen of Australia’s University of New South Wales and Michael Farrell of the country’s National Drug and Alcohol Research Centre suggested that when co-administered with opioids, cannabis may enable reduced opioid doses without decreasing the pain relief. MAINE STUDY PROMISING.
Expert insights. Personalized for you.
100 
Let's personalize your content